PATENT CLAIM ANALYSIS

Application Number: 15879052
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "04400A"]

Abstract:
The present disclosure provides compositions and methods for improving the efficacy of enzyme replacement therapy for lysosomal storage diseases.

Claim (Index 7):
The method according to  claim 5 , wherein the delivery vehicle is a PEGylated liposome or nanoparticle, oligonucleotide nanoparticle, cyclodextrin polymer (CDP)-based nanoparticle, biodegradable polymeric nanoparticle formulated with poly-(D,L-lactide-co-glycolide) (PLGA), Poly-lactic acid (PLA), or N-(2-hydroxypropyl)methacrylamide (HPMA), lipid nanoparticle (LNP), stable nucleic acid lipid particle (SNALP), or vitamin A coupled lipid nanoparticle.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 86.0
- Lexical Diversity: 1.05263
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13391265', '13253005', '12801404', '14936568', '15438375']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7650532056833496
- 35 USC 102 Novelty (BERT): 0.5174966934234
- Combined Prediction Score: 0.7402975544573547
- Mean Citation Score: 234.578618
- Max Citation Score: 247.39505
- Similarity Product: 138.49749226801097

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test